Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1986 Apr;203(4):371–378. doi: 10.1097/00000658-198604000-00006

Prostaglandin E1 and survival in patients with the adult respiratory distress syndrome. A prospective trial.

J W Holcroft, M J Vassar, C J Weber
PMCID: PMC1251120  PMID: 3516085

Abstract

A 7-day infusion of prostaglandin E1 (PGE1), an immunomodulator, was evaluated in a prospective, randomized, placebo-controlled, double-blinded trial in surgical patients with the adult respiratory distress syndrome (ARDS). The drug seemed to improve pulmonary function--only two PGE1 patients died with severe pulmonary failure compared with nine placebo patients (p = 0.01). Survival at 30 days after the end of the infusion--the predetermined end point of the study--was significantly better in the patients given PGE1 (p = 0.03), with 15 of 21 PGE1 patients (71%) alive at this time compared with seven of 20 placebo patients (35%). Improvement in overall survival in the PGE1 patients did not reach statistical significance (p = 0.08). Overall survival in patients initially free of severe organ failure, however, was significantly better in the PGE1 patients (p = 0.03). Of the six PGE1 patients free of severe organ failure at time of entry, all survived to leave the hospital; of the 10 placebo patients initially free of severe organ failure, four survived. The drug had no serious side effects and did not potentiate susceptibility to infection. PGE1 is a promising agent for the treatment of ARDS.

Full text

PDF
371

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blaisdell F. W., Lim R. C., Jr, Amberg J. R., Choy S. H., Hall A. D., Thomas A. N. Pulmonary microembolism. A cause of morbidity and death after major vascular surgery. Arch Surg. 1966 Nov;93(5):776–786. doi: 10.1001/archsurg.1966.01330050080012. [DOI] [PubMed] [Google Scholar]
  2. Borzotta A. P., Polk H. C., Jr Multiple system organ failure. Surg Clin North Am. 1983 Apr;63(2):315–336. doi: 10.1016/s0039-6109(16)42984-1. [DOI] [PubMed] [Google Scholar]
  3. Faist E., Baue A. E., Dittmer H., Heberer G. Multiple organ failure in polytrauma patients. J Trauma. 1983 Sep;23(9):775–787. doi: 10.1097/00005373-198309000-00002. [DOI] [PubMed] [Google Scholar]
  4. Fantone J. C., Marasco W. A., Elgas L. J., Ward P. A. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production. Am J Pathol. 1984 Apr;115(1):9–16. [PMC free article] [PubMed] [Google Scholar]
  5. Fein A. M., Lippmann M., Holtzman H., Eliraz A., Goldberg S. K. The risk factors, incidence, and prognosis of ARDS following septicemia. Chest. 1983 Jan;83(1):40–42. doi: 10.1378/chest.83.1.40. [DOI] [PubMed] [Google Scholar]
  6. Ferreira S. H., Vane J. R. Prostaglandins: their disappearance from and release into the circulation. Nature. 1967 Dec 2;216(5118):868–873. doi: 10.1038/216868a0. [DOI] [PubMed] [Google Scholar]
  7. Fowler A. A., Hamman R. F., Good J. T., Benson K. N., Baird M., Eberle D. J., Petty T. L., Hyers T. M. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med. 1983 May;98(5 Pt 1):593–597. doi: 10.7326/0003-4819-98-5-593. [DOI] [PubMed] [Google Scholar]
  8. Fry D. E., Garrison R. N., Heitsch R. C., Calhoun K., Polk H. C., Jr Determinants of death in patients with intraabdominal abscess. Surgery. 1980 Oct;88(4):517–523. [PubMed] [Google Scholar]
  9. Golub M., Zia P., Matsuno M., Horton R. Metabolism of prostaglandins A1 and E1 in man. J Clin Invest. 1975 Dec;56(6):1404–1410. doi: 10.1172/JCI108221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lewis A. B., Takahashi M., Lurie P. R. Administration of prostaglandin E1 in neonates with critical congenital cardiac defects. J Pediatr. 1978 Sep;93(3):481–485. doi: 10.1016/s0022-3476(78)81171-8. [DOI] [PubMed] [Google Scholar]
  11. Meakins J. L. Clinical importance of host resistance to infection in surgical patients. Adv Surg. 1981;15:225–255. [PubMed] [Google Scholar]
  12. Pepe P. E., Potkin R. T., Reus D. H., Hudson L. D., Carrico C. J. Clinical predictors of the adult respiratory distress syndrome. Am J Surg. 1982 Jul;144(1):124–130. doi: 10.1016/0002-9610(82)90612-2. [DOI] [PubMed] [Google Scholar]
  13. Pine R. W., Wertz M. J., Lennard E. S., Dellinger E. P., Carrico C. J., Minshew B. H. Determinants of organ malfunction or death in patients with intra-abdominal sepsis. A discriminant analysis. Arch Surg. 1983 Feb;118(2):242–249. doi: 10.1001/archsurg.1983.01390020084014. [DOI] [PubMed] [Google Scholar]
  14. Pitlick P., French J. W., Maze A., Kimble K. J., Ariagno R. L., Reitz B. A. Long-term low-dose prostaglandin E1 administration. J Pediatr. 1980 Feb;96(2):318–320. doi: 10.1016/s0022-3476(80)80838-9. [DOI] [PubMed] [Google Scholar]
  15. Rinaldo J. E., Rogers R. M. Adult respiratory-distress syndrome: changing concepts of lung injury and repair. N Engl J Med. 1982 Apr 15;306(15):900–909. doi: 10.1056/NEJM198204153061504. [DOI] [PubMed] [Google Scholar]
  16. Schuler J. J., Flanigan D. P., Holcroft J. W., Ursprung J. J., Mohrland J. S., Pyke J. Efficacy of prostaglandin E1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease. Results of a prospective randomized, double-blind, multicenter clinical trial. J Vasc Surg. 1984 Jan;1(1):160–170. doi: 10.1067/mva.1984.avs0010160. [DOI] [PubMed] [Google Scholar]
  17. Slotman G. J., Machiedo G. W., Casey K. F., Novak R. T., Rush B. F., Jr The hemodynamic effects of prostaglandin E1 (PGE1) in acute hypoxic respiratory failure. Adv Shock Res. 1980;3:283–289. [PubMed] [Google Scholar]
  18. Stenson W. F., Parker C. W. Prostaglandins, macrophages, and immunity. J Immunol. 1980 Jul;125(1):1–5. [PubMed] [Google Scholar]
  19. Tilney N. L., Lazarus J. M. Acute renal failure in surgical patients. Causes, clinical patterns, and care. Surg Clin North Am. 1983 Apr;63(2):357–377. doi: 10.1016/s0039-6109(16)42986-5. [DOI] [PubMed] [Google Scholar]
  20. Wedmore C. V., Williams T. J. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature. 1981 Feb 19;289(5799):646–650. doi: 10.1038/289646a0. [DOI] [PubMed] [Google Scholar]
  21. Weissmann G., Smolen J. E., Korchak H. Prostaglandins and inflammation: receptor/cyclase coupling as an explanation of why PGEs and PGI2 inhibit functions of inflammatory cells. Adv Prostaglandin Thromboxane Res. 1980;8:1637–1653. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES